TransThera Sciences (Nanjing), Inc. has notified shareholders that its board of directors will convene on 26 August 2026 in Hong Kong. The meeting’s agenda includes three primary items:

1. Review and approval of the unaudited consolidated interim results for the six months ended 30 June 2026. 2. Consideration of an interim dividend declaration and payment. 3. Discussion of other routine matters.

The announcement, released on 14 August 2026, was signed by Dr. Frank Wu, who serves as both Chairman and Chief Executive Officer. The current board comprises Executive Directors Dr. Frank Wu and Mr. Wu Di; Non-Executive Director Ms. Jia Zhongxin; and Independent Non-Executive Directors Ms. Chui Hoi Yam, Mr. Feng Weibo, and Mr. Li Shu Pai.